144,448 members

Skip to content. | Skip to navigation

News

NICE recommends new ‘chemotherapy-free’ treatment for lymphoma

* Join in to find members with similar interests, make connections, enlist on networks and start sharing information. It's useful and it's free.
 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

NICE recommends new ‘chemotherapy-free’ treatment for lymphoma

A new treatment option for patients with previously treated follicular lymphoma (grade 1 to 3A) has been approved by NICE.

The new drug, lenalidomide (Revlimid, Celgene), fights cancer cells in a different way to current treatments, interfering with cell processes to halt the growth of tumours and stopping them from producing their own blood vessels. Lenalidomide has been recommended for use with rituximab (MabThera, Roche), an anti-CD20 antibody that sticks to cancer cells to help the immune system recognise and kill them. More...